Blog Summarizes News From AIDS 2014
The Center for Global Health Policy’s “Science Speaks” is live-blogging this week from the AIDS 2014 conference in Melbourne, Australia.
Science Speaks: AIDS 2014: PrEP is a beginning with new prevention technologies in the works
“Kenneth Mayer of the Fenway Institute and the Harvard School of Public Health offered a comprehensive look at HIV prevention technologies to conference delegates at the opening plenary on Thursday while underscoring the critical behavioral underpinnings associated with making them effective in preventing HIV infection…” (Lubinski, 7/23).
Science Speaks: AIDS 2014: Financing the new global HIV treatment vision — advocacy and economics
Arin Dutta, senior economist with the Futures Group’s Health Policy Project, and Ron MacInnis, deputy director for HIV for the project, write in a guest post about the “90-90-90 by 2020” treatment vision presented by UNAIDS (Lubinski, 7/23).
Science Speaks: AIDS 2014: Activists hold die-in to protest high price of Gilead’s hepatitis C drug
“Activists surprised Gilead corporate executives today with a ‘die-in’ to protest the pricing of Gilead’s hepatitis C drug, Solvaldi (sofosbuvir)…” (Lubinski, 7/24).
Science Speaks: AIDS 2014: ‘What good are interventions if we live like we have a gun to our heads?’
“Laurindo Garcia, a gay man living with HIV in the Philippines offered a moving conclusion to the opening plenary in Melbourne on Thursday, speaking to gay and transgender communities’ limited access to lifesaving services…” (Lubinski, 7/24).
Science Speaks: AIDS 2014: Men who have sex with men and transgender women have risks and resilience
“During the opening plenary [Thursday], Beatriz Grinszteijn offered insights about men who have sex with men and transgender women, echoing many of the themes raised in this conference…” (Lubinski, 7/24).